Updated : 1 month, 2 weeks ago IST
Noida (Uttar Pradesh) [India], Mar 8 (ANI): Jubilant Life Sciences said on Friday that the US Food and Drug Administration (USFDA) has issued a warning letter after conducting an inspection at its manufacturing facility in Roorkee, Uttarakhand.
Updated : 1 month, 3 weeks ago IST
New Delhi [India], Feb 26 (ANI): Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food and Drug Administration at the company’s primary manufacturing facility with Zero 483 observations. With successful inspection of its formulat
Updated : 8 months, 3 weeks ago IST
New Delhi [India], July 30 (NewsVoir): Morepen Laboratories Ltd. has received US FDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.
Updated : 1 year, 3 months ago IST
New Delhi [India], Jan 22 (ANI-NewsVoir): Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 per cent rise in its net profit in Q3 of FY 2017-18 at Rs. 9.67 crore, despite a marginal rise in its net sales revenue at Rs. 139.87 crore, compared to the co
Updated : 1 year, 4 months ago IST
New Delhi [India], Dec 20 (ANI-NewsVoir): The United States Food and Drug Administration (USFDA) has cleared Montelukast Sodium, a bulk drug / API manufactured by Morepen Laboratories Ltd., for sale in the US market. This gives Morepen an entry into the Rs. 2000 crore (Approx. $ 300 million)
Updated : 2 years, 8 months ago IST
New Delhi, Aug 24 (ANI): Strides Shasun in a BSE filing today announced receiving an approval from the US health regulator for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.